Global Pharmaceutical Manufacturing Leadership Forum

The International Leadership Forum (ILF) was established in April 1990 to enable senior management to discuss issues of common interest among their colleagues worldwide and to meet with senior regulatory agency personnel to discuss ways to improve efficiency and safety. The International Leadership also provided leadership, direction, and resources to initiate the development of baseline guides to establish science-based standards for industry reference and compliance.

In 2016, the group repositioned and renamed itself the Global Pharmaceutical Manufacturing Leadership Forum (GPMLF).

The Global Pharmaceutical Manufacturing Leadership Forum exists to provide a neutral setting in which senior pharmaceutical industry thought leaders can engage in dialogue around critical industry issues with the objective to progress those areas of common interest to membership into tangible action. The Global Pharmaceutical Manufacturing Leadership Forum meets twice annually for one day. Meetings usually take place at the ISPE Europe Annual Conference in the spring and at the ISPE Annual Meeting & Expo in the fall. Ad hoc meetings are held throughout the year by the core team and various task teams for planning purposes and to progress the Global Pharmaceutical Manufacturing Leadership Forum agenda


Global Pharmaceutical Manufacturing Leadership Forum (GPMLF) White Paper

This document addresses critical aspects of sterile manufacturing, provides practical guidance for the industry as regulatory expectations continue to evolve, and consolidates current best practices across the field.

GPMLF White Paper

 


Relationship to ISPE

  • ISPE will work with the GPMLF on mutually agreed upon initiatives that fit within ISPE’s scope, vision, and strategy. ISPE values the input of this Forum and their support of ISPE activities.
  • ISPE commits to continuing to partner with GPMLF at ISPE Conferences. ISPE will act as the conference partner to GPMLF at ISPE events, hosting, and coordinating their meetings.
  • ISPE may provide publishing support for GPMLF work products, including editorial support and posting of work products on the GPMLF web-page (located within the ISPE website).

Governance:

  • A GPMLF core group will be identified, and these members are intended to garner participation from the major industry sectors. This group will serve as the leadership team of GPMLF
  • Additional individuals can be invited to attend meetings to support the specific agenda topics of the meeting organized by a core steering team

Leadership Team

James Breen
Vice President, Global Engineering and Technology
Johnson & Johnson Innovative Medicines
David Churchward
Head of Operations Quality Compliance and External Affairs
AstraZeneca
Joseph Famulare
Principal
Famulare Consulting LLC
Bob Iser
Global Head, Quality Policy & Advocacy
Genentech/Roche Inc
Frances Zipp
President/CEO
Lachman Consultant Services